x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Market Lens

Welcome to Market Lens, your fresh take on the financial markets.Each week, we break down the latest headlines, offer clear analysis of stocks, ETFs, and major trends, and share practical trading strategies and investing tips you can use right away. You’ll get honest conversations about risks and opportunities, plus short educational segments to help you build your financial skills and make smarter decisions.Tune in to cut through the noise, stay ahead of the markets, and get the edge you need—one

business investing

All Episodes

1:28

iRobot Financial Collapse and Bankruptcy Risk

Market Lens ·

2025/11/11

Send us a text This episode provide an urgent overview of the severe financial distress facing iRobot Corporation, the maker of the Roomba robot vacuum, following the collapse of a potential sale to Amazon and subsequent failed acquisition talks. The core issue is the company’s deteriorating liquidity, highlighted by a 24.6% year-over-year drop in Q3 2025 revenue and a warning that it has no sources upon which it can draw for additional capital, leading management to express "substantial doub...

en-us

1:41

SoftBank Sells Nvidia Stake for OpenAI Investment

Market Lens ·

2025/11/11

Send us a text This podcast focus on SoftBank's sale of its entire stake in Nvidia for approximately $5.8 billion to finance a significant investment in OpenAI. Multiple articles confirm the sale, noting that SoftBank is aggressively pursuing an "all in" strategy on AI, particularly with the ChatGPT maker. This move has triggered a debate among investors, particularly on platforms like Reddit, regarding whether SoftBank is simply taking profit or if the sale signals that a broader AI valuatio...

en-us

1:33

Warren Buffett: Legacy, Farewell to Come

Market Lens ·

2025/11/10

Send us a text This episode discusses the impending retirement of Warren Buffett as CEO of Berkshire Hathaway and the enduring principles of his value investing philosophy. The first article reports on the upcoming release of Buffett’s farewell letter to shareholders, which will mark the end of his more than six decades leading the conglomerate and signal a cautious investment approach. The second source offers a commentary on the wistful end of Buffett’s influential annual letters, reflectin...

en-us

1:43

Pfizer Acquires Metsera After Obesity Bidding War

Market Lens ·

2025/11/10

Send us a text This podcast details the conclusion of a fierce bidding war between pharmaceutical giants Pfizer and Novo Nordisk for the obesity biotech startup, Metsera, with Pfizer ultimately prevailing in a $10 billion acquisition. Metsera, known for its next-generation weight-loss pipeline, including potential once-monthly injectable therapies, initially agreed to a deal with Pfizer before Novo Nordisk submitted increasingly high, unsolicited bids. A critical turning point in the competit...

en-us

1:46

Coinbase Relaunches US Token Sales Platform

Market Lens ·

2025/11/10

Send us a text This podcast focus on that Coinbase has launched a new platform for direct token sales to investors, marking the first time since 2018 that U.S. retail traders can participate in public crypto token sales, often referred to as Initial Coin Offerings (ICOs). This new system is designed to democratize access and prevent the issues seen during the 2017–2018 ICO boom by employing an algorithmic allocation method that prioritizes smaller requests to ensure broader distribution rathe...

en-us

1:56

Monday.com Plunges Despite Record Earnings

Market Lens ·

2025/11/10

Send us a text This episode provides an analysis of the financial results and market reaction to monday.com's (MNDY) Q3 2025 earnings report, focusing on the concept of company guidance versus consensus estimates. The articles and earnings transcript confirm that the company achieved a strong beat on Q3 revenue and non-GAAP earnings, while also reporting record non-GAAP operating income, suggesting robust financial health and momentum in moving upmarket. Despite the strong performance, the st...

en-us

1:36

Boeing South Carolina: Economic Impact and Expansion

Market Lens ·

2025/11/10

Send us a text This podcast examines the economic impact and future expansion of Boeing's 787 Dreamliner facility in South Carolina. One source, from the Richmond Federal Reserve, analyzes the initial $1 billion recruitment deal, concluding that the plant successfully boosted the state's aerospace sector by generating over 6,000 jobs, which was more than promised, and delivered good value for taxpayers. The other two sources focus on a new, subsequent $1 billion expansion of the North Charles...

en-us

1:57

Rumble's All-Stock Acquisition of Northern Data

Market Lens ·

2025/11/10

Send us a text This episode concerns Rumble Inc.'s pursuit of acquiring the German AI firm, Northern Data AG, through an all-stock transaction. The proposed acquisition, which Rumble confirmed interest in, is a strategic move to pivot the video-sharing platform into the AI cloud computing sector, leveraging Northern Data's substantial data center and GPU infrastructure, including Nvidia H100 and H200 chips. A key element of the deal involves Tether, the stablecoin issuer and Northern Data's m...

en-us

1:33

Market Outlook for This Week (Nov 10)

Market Lens ·

2025/11/09

Send us a text This episode offers comprehensive market outlooks and trading strategies for the week of November 10–14, 2025, with both sources emphasizing the importance of corporate earnings releases and the impact of an ongoing U.S. government shutdown. The first source, from Ki-Wealth, presents a detailed technical analysis and tactical trading plan for the S&P 500 and Nasdaq 100 indices, noting a preceding market pullback and projecting a bearish bias for the upcoming week. The secon...

en-us

1:38

Eli Lilly's Collaboration with SanegeneBio on RNAi...

Market Lens ·

2025/11/09

Send us a text This episode focus on the RNA interference (RNAi) therapeutics market, highlighting both the broader industry landscape and a major strategic collaboration. One source provides an overview of eight leading RNAi therapeutics companies, such as Alnylam and Roche, detailing their proprietary delivery platforms and competitive positions in treating various diseases. The remaining sources all report on a significant agreement between Eli Lilly and SanegeneBio, where Lilly is investi...

en-us

1:29

Why Wall St Backs Micron's Bullish Investment Thesis?

Market Lens ·

2025/11/08

Send us a text This podcast provides an extensive overview of the bullish investment thesis for Micron Technology, arguing that the stock is currently undervalued despite a significant price surge. The core argument centers on the AI-driven memory boom, noting that Micron has secured substantial market share in High-Bandwidth Memory (HBM), leading to a massive increase in related revenues. Furthermore, the company exhibits strong financial fundamentals, with record revenues, soaring adjusted ...

en-us

1:38

Disney's Big Pivot: How Streaming Profits and Theme...

Market Lens ·

2025/11/08

Send us a text This episode offers a multifaceted look at The Walt Disney Company's financial performance and strategic direction across its various segments. The Nasdaq excerpt provides an in-depth investment analysis recommending a "Hold" position on Disney stock, noting its discounted valuation despite significant growth in its Experiences segment and achieving a streaming profitability milestone. Separately, a Marketing Brew article discusses Disney's ongoing commitment to its linear tele...

en-us

2:00

Supreme Court Scrutiny of Trump Tariffs Under IEEPA

Market Lens ·

2025/11/08

Send us a text This podcast provides an overview of the legal and economic implications surrounding the Supreme Court's consideration of tariffs imposed by the Trump administration under the International Economic Emergency Powers Act (IEEPA). The articles from SCOTUSblog, Brookings, and the Atlantic Council address the skepticism expressed by the Supreme Court regarding the President's authority to unilaterally impose such widespread tariffs, arguing that the IEEPA statute likely does not gr...

en-us

1:36

Meta's $600 Billion AI Data Center Investment in the US

Market Lens ·

2025/11/08

Send us a text This episode provides a comprehensive look at Meta's massive investment in artificial intelligence (AI) infrastructure across the United States, committing over $600 billion by 2028 primarily for AI-optimized data centers. The Meta newsroom source highlights the company's intention to drive economic growth, support over 35,000 jobs, and strengthen local communities through investments in municipal infrastructure and grants, all while striving for water positive operations by 20...

en-us

1:56

Brazil's Paradox: Oil, Investment, and Energy Transition

Market Lens ·

2025/11/07

Send us a text This episode focus on Brazil's energy transition and the paradoxical role of oil revenue in funding green initiatives. Several sources detail Brazil's efforts, including the Eco Invest Brasil program and multi-billion-dollar commitments from multilateral agencies like the IDB to boost foreign investment and reduce currency risk in decarbonization projects. Conversely, Brazil's state-controlled oil company, Petrobras, is expanding oil and gas exploration, particularly in the Equ...

en-us

1:53

ESPN-DraftKings Partnership After Penn Exit

Market Lens ·

2025/11/07

Send us a text This episode details the early termination of the online sports betting partnership between ESPN and PENN Entertainment, which operated the ESPN Bet platform, due to its failure to meet market share targets. This abrupt ending of the expensive, ten-year deal, signed in 2023, results in PENN Entertainment rebranding its sportsbook app as theScore Bet by December 1, 2025, while retaining nearly three million user accounts. Simultaneously, ESPN announced a new multi-year agreement...

en-us

2:01

Comcast's Proposed ITV Acquisition

Market Lens ·

2025/11/07

Send us a text This podcast focus primarily on the proposed acquisition of ITV's media and entertainment division by Comcast, the American telecommunications giant that owns Sky. This potential deal, valued around £1.6 billion to $2.1 billion, involves the sale of ITV's linear channels and the streaming platform ITVX, but excludes the lucrative ITV Studios production arm. The sources analyze the strategic rationale behind the move, noting that combining Sky and ITV's advertising operations co...

en-us

1:53

Peloton's Turnaround: Subscription Value

Market Lens ·

2025/11/07

Send us a text This podcast centers on the financial outlook and turnaround strategy of Peloton, focusing heavily on the value of its subscription business despite challenges in hardware sales and significant debt. One Reddit post argues that Peloton is undervalued when its high-margin, growing subscription revenue is considered separately from its declining product revenue, even comparing it favorably to Netflix’s gross margins. Complementary news articles report that Peloton's shares jumped...

en-us

1:34

Tesla's AI Chip Strategy: Intel Partnership

Market Lens ·

2025/11/07

Send us a text This episode provides an overview of a potential, but yet unsigned, partnership between Tesla and Intel regarding the manufacturing of Tesla’s next-generation AI chips. Driven by its growing demand for custom silicon to power its autonomous driving (FSD) and robotics ambitions, Tesla CEO Elon Musk proposed the idea of building a massive internal "terafab" but also mentioned discussions with Intel Foundry as a strategic alternative to secure high-volume production. This move sig...

en-us

1:36

GLP-1 Drug Stocks Risk: Medicare Deals vs. 2026...

Market Lens ·

2025/11/06

Send us a text This episode offers conflicting reports regarding the Trump administration's policy on Medicare coverage for GLP-1 drugs used for weight loss. The first source, an article from Investopedia dated November 2025, claims that a new plan would cover popular drugs like Ozempic and Wegovy for Medicare patients for as little as $50 a month, due to negotiated lower prices with pharmaceutical companies. Conversely, the second source, a Pharmaceutical Technology article from April 2025, ...

en-us

98 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...